Willingness to pay for a hypothetical Malaria vaccine in Brazil: a cross-sectional study and the implications

Maria José Labis da Costa, Gesiane Cavalcante Nascimento, Thannuse Silva Athie, Juliana de Sales Silva, Edna Afonso Reis, Antony Paul Martin, Brian Godman, Isabella Piassi Dias Godói

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: Malaria is an infection caused by protozoa of genus Plasmodium, considered the one associated with increasingly large outbreaks. Methods: A cross-sectional study was conducted with residents in the northern region of Brazil on the willingness to pay (WTP) for a hypothetical vaccine against malaria (effective protection of 80%). Results: Of 616 people interviewed, most interviewees were female (61%) and were employed (97%). The median individual maximum WTP for a hypothetical malaria vaccine was US$11.90 (BRL 50). Conclusion: The northern region of Brazil is one of the largest markets for a malaria vaccine due to its epidemiological relevance. Consequently, economic studies will be important to assist in the assessment of the potential price and value of new vaccines.
Original languageEnglish
Pages (from-to)263-274
Number of pages12
JournalJournal of Comparative Effectiveness Research
Volume11
Issue number4
Early online date14 Jan 2022
DOIs
Publication statusPublished - 1 Mar 2022

Keywords

  • malaria
  • willingness to pay
  • vaccine
  • Brazil

Fingerprint

Dive into the research topics of 'Willingness to pay for a hypothetical Malaria vaccine in Brazil: a cross-sectional study and the implications'. Together they form a unique fingerprint.

Cite this